ST
AZN icon

Spinnaker Trust’s AstraZeneca AZN Stock Holding History

Spinnaker Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,400
Closed -$698K – 199
2016
Q1 		$698K Buy
12,400
+185
+2% +$11.1K 0.1% 118
2015
Q4 		$829K Buy
12,215
+455
+4% +$29.8K 0.12% 109
2015
Q3 		$748K Buy
11,760
+58
+0.5% +$3.82K 0.11% 116
2015
Q2 		$746K Buy
11,702
+508
+5% +$34.8K 0.11% 114
2015
Q1 		$766K Sell
11,194
-980
-8% -$68.1K 0.11% 114
2014
Q4 		$857K Buy
12,174
+1,184
+11% +$84.8K 0.13% 103
2014
Q3 		$785K Buy
10,990
+587
+6% +$43K 0.13% 107
2014
Q2 		$773K Sell
10,403
-256
-2% -$18.5K 0.13% 100
2014
Q1 		$692K Buy
+10,659
New +$688K 0.11% 106

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Spinnaker Trust's AZN Position: Q2 2016 in Review

Spinnaker Trust sold out of AstraZeneca (AZN) in Q2 2016, closing a stake of 12,400 shares — an estimated $698K sold.

Spinnaker Trust first reported a position in AZN in Q1 2014 and held it in 9 quarters. The position peaked at $857K in Q4 2014. 398 funds tracked by Wall St. Rank hold AZN as of Q2 2016.

  • Spinnaker Trust reported no remaining AstraZeneca position as of Q2 2016 after selling out during the quarter.
  • Spinnaker Trust sold 12,400 AstraZeneca shares in Q2 2016, an estimated $698K.
  • Spinnaker Trust first reported a position in AstraZeneca in Q1 2014 and held it in 9 quarters.
  • Spinnaker Trust's AstraZeneca position peaked at $857K in Q4 2014.
  • 398 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2016.

Based on Spinnaker Trust's 13F filing for Q2 2016, filed 1 Aug 2016.